About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles

Articles

The EXCEL Trial: The Interventionalists’ Perspective

George William Hunter, Vinoda Sharma, Chetan Varma,

Published:

Citation: European Cardiology Review 2021;16:e01.

The EXCEL Trial: The Surgeons’ Perspective

Marjan Jahangiri, Krishna Mani, Martin T Yates,

Published:

Citation: European Cardiology Review 2020;15:e67.

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?

Mahmoud Abdelnabi, Abdallah Almaghraby, Yehia Saleh,

Published:

Citation: European Cardiology Review 2020;15:e06.

Antithrombotic Therapy After TAVI

Leslie Marisol Lugo, Rafael Romaguera, Joan Antoni Gómez-Hospital,

Published:

Citation: European Cardiology Review 2020;15:e09.